Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Eurobio ScientificSTU:E8TN +0.49%69 Gross Margin % is 44.42% as of Dec. 2025, which is 1% below its 10-year median of 44.66. GuruFocus rates STU:E8TN with a GF Score™ of 69/100 and a GF Value™ of €25.22 (Modestly Undervalued). The stock has 5 warning signs investors should review. Among 806 Medical Devices & Instruments companies, Eurobio Scientific ranks worse than 60.55% on this metric.
Eurobio Scientific gross margin has been in long-term decline. The average rate of decline per year is -5.1%.
The historical rank and industry rank for Eurobio Scientific's Gross Margin % or its related term are showing as below:
STU:E8TN'
s Gross Margin % Range Over the Past 10 Years
Min: 29.91 Med: 44.66 Max: 58.46
Current: 45.58
During the past 13 years, the highestGross Margin % of Eurobio Scientific was 58.46%. The lowest was 29.91%. And the median was 44.66%.
STU:E8TN's Gross Margin % is ranked worse than 60.55% of 806
companies
in the Medical Devices & Instruments industry
Industry Median: 52.115
vs STU:E8TN: 45.58
Eurobio Scientific had a gross margin of 44.42% for the quarter that ended in Dec. 2025 => Durable competitive advantage
The 5-Year average Growth Rate of Gross Margin for Eurobio Scientific was -5.10% per year.
Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.
Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %
1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key
Eurobio Scientific had a gross margin of 44.42% for the quarter that ended in Dec. 2025 => Durable competitive advantage
Be Aware
If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.
Eurobio Scientific Gross Margin % Related Terms
Eurobio Scientific Gross Margin % Historical Data
* Premium members only.
The historical data trend for Eurobio Scientific's Gross Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
STU:E8TN vs ABT, SYK, MDT: Gross Margin % Comparison
For the Medical Devices subindustry, Eurobio Scientific's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Eurobio Scientific Gross Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Eurobio Scientific's Gross Margin % distribution charts can be found below:
* The bar in red indicates where Eurobio Scientific's Gross Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.
Eurobio Scientific (STU:E8TN) has a Gross Margin % of 44.42% as of Dec. 2025. Gross margin is the ratio of total gross profit to net sales. View historical data on Eurobio Scientific and its competitors. This is near median its historical median of 44.66. Over the past decade, Eurobio Scientific's Gross Margin % has ranged from 29.91 to 58.46. According to the industry distribution chart, Eurobio Scientific ranks #488 out of 806 companies in the Medical Devices & Instruments industry, placing it in the top 60.5%.
Is Eurobio Scientific's Gross Margin % too high?
Eurobio Scientific's current Gross Margin % of 44.42% is near median its 10-year median of 44.66. Over the past 10 years, this metric has ranged from a low of 29.91 to a high of 58.46. The Medical Devices & Instruments industry median Gross Margin % is 52.12. Eurobio Scientific's value of 44.42% is 14.8% below this industry median. Based on the distribution chart, Eurobio Scientific ranks #488 out of 806 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, Eurobio Scientific has a GF Score™ of 69/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Eurobio Scientific's Gross Margin % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Eurobio Scientific ranks #488 out of 806 companies for Gross Margin %. This places Eurobio Scientific in the lower half of its industry. The industry median Gross Margin % is 52.12. Eurobio Scientific's value of 44.42% is 14.8% below this benchmark. Historically, Eurobio Scientific's own Gross Margin % has ranged from 29.91 to 58.46 over the past decade. While the company's 10-year median is 44.66 vs. the industry median of 52.12, Eurobio Scientific has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Gross Margin % for a Medical Devices & Instruments company?
The median Gross Margin % among Medical Devices & Instruments companies is 52.12, based on 806 companies in the industry. Companies in the top quartile (top 25%) have a Gross Margin % significantly above this median, while those in the bottom quartile fall well below. However, Gross Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Eurobio Scientific's current Gross Margin % of 44.42% is 14.8% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Gross Margin % mean?
A high Gross Margin % can signal that a stock is expensive relative to its fundamentals. Gross margin is the ratio of total gross profit to net sales. View historical data on Eurobio Scientific and its competitors. For the Medical Devices & Instruments industry, the median Gross Margin % is 52.12 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Eurobio Scientific's current Gross Margin % is 44.42%, which is near median its own 10-year median of 44.66. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Eurobio Scientific stock overvalued right now?
Based on GuruFocus' analysis, Eurobio Scientific (STU:E8TN) is currently considered Modestly Undervalued. The stock's GF Value™ is €25.22, compared to a current price of €20.40 — trading 19.1% below its estimated fair value. The current Gross Margin % is 44.42%, which is near median its 10-year median of 44.66 and 14.8% below the Medical Devices & Instruments industry median of 52.12. Eurobio Scientific's overall GF Score™ is 69/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Gross Margin % calculated?
Gross Margin % is calculated from a company's financial statements. For Eurobio Scientific (STU:E8TN), the current Gross Margin % is 44.42% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Eurobio Scientific (STU:E8TN) Overvalued in 2026?
Based on GuruFocus' analysis, Eurobio Scientific stock appears to be undervalued.
The current stock price of €20.40 is trading 19.1% below its estimated GF Value™ of €25.22.
GuruFocus considers Eurobio Scientific to be Modestly Undervalued.
Key valuation signals for STU:E8TN:
Gross Margin %: 44.42% (near median its 10-year median of 44.66)
GF Value™: €25.22 vs. price of €20.40 (19.1% below fair value)
Industry Position: 14.8% below the Medical Devices & Instruments median (#488 of 806)
No single metric tells the full story. See the STU:E8TN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Eurobio Scientific is one of the leading providers of specialty in vitro diagnostics and life-science solutions. The product portfolio includes Tetanos Quick Stick, BJI InoPlex, AlloMap, and TEDAC Consortium.
69GF Score
Get the complete analysis for STU:E8TN
Gross Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
STU:E8TN has been successfully added to your 
